(Q38756772)

6 September 2017

title

Therapy-induced microenvironmental changes in cancer (English)

1 reference

6 September 2017

5

Laurence Zitvogel

0 references

Guido Kroemer

series ordinal

4

object named as

Guido Kroemer

0 references

Yuting Ma

series ordinal

1

object named as

Yuting Ma

1 reference

6 September 2017

3

Jonathan M Pitt

1 reference

6 September 2017

Heng Yang

2

1 reference

6 September 2017

publication date

2 March 2016

1 reference

Journal of Molecular Medicine

6 September 2017

published in

1 reference

6 September 2017

volume

94

1 reference

6 September 2017

issue

5

1 reference

6 September 2017

page(s)

497-508

1 reference

Tumors as organs: complex tissues that interface with the entire organism

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

TSPAN12 is a critical factor for cancer-fibroblast cell contact-mediated cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Immune cell promotion of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Deciphering and reversing tumor immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Tumor angiogenesis: molecular pathways and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Lymphangiogenesis and lymphatic vessel remodelling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Chemotherapy and radiotherapy: cryptic anticancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Immune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Immunogenic cell death in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The gut microbiota, bacterial metabolites and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Microbiota modulation of myeloid cells in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The essence of senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Senescence in tumours: evidence from mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Tumour biology: senescence in premalignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Chemokine signaling via the CXCR2 receptor reinforces senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

A complex secretory program orchestrated by the inflammasome controls paracrine senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The impact of the endoplasmic reticulum protein-folding environment on cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Proteostasis control by the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Endoplasmic reticulum stress in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Overexpression of glucose-regulated protein 78 in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Activation of the unfolded protein response is associated with favorable prognosis in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Tissue-specific Autophagy Alterations and Increased Tumorigenesis in Mice Deficient in Atg4C/Autophagin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy suppresses tumorigenesis through elimination of p62

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy suppresses tumor progression by limiting chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy as a target for anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

TET2 as an epigenetic master regulator for normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Chronic inflammation and cytokines in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The immune contexture in human tumours: impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The dual role of tumor necrosis factor (TNF) in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Interleukin-10 and the immune response against cancer: a counterpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Exosomes in tumor microenvironment influence cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Malignant effusions and immunogenic tumour-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Trial watch: IDO inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Immunity, inflammation and cancer: a leading role for adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Regulation of immune responses by prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Regulation of immune responses by L-arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The roles of TGFβ in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Mechanisms of disseminated cancer cell dormancy: an awakening field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The metastatic niche: adapting the foreign soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Trial Watch: Anticancer radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Molecular mechanisms of ATP secretion during immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autosis and autophagic cell death: the dark side of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy-dependent ATP release from dying cells via lysosomal exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Necroptosis: the release of damage-associated molecular patterns and its physiological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Management of febrile neutropenia: ESMO Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Lack of autophagy in the hematopoietic system leads to loss of hematopoietic stem cell function and dysregulated myeloid proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

A critical role for the autophagy gene Atg5 in T cell survival and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Induction of autophagy is essential for monocyte-macrophage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy is required for CSF-1-induced macrophagic differentiation and acquisition of phagocytic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy modulates cell migration and β1 integrin membrane recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Autophagy and cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Cancer and the gut microbiota: an unexpected link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Gastrointestinal malignancy and the microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Microbes, microbiota, and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Cancer and the microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Microbiota organization is a distinct feature of proximal colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Size does not matter: commensal microorganisms forge tumor-promoting inflammation and anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Microbiome and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Antibiotic use in relation to the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1401-8

Influence of Antibiotic Treatment on Breast Carcinoma Development in Proto-neu Transgenic Mice

21 January 2018

1 reference

12 December 2020

Tumor cells hijack macrophages via lactic acid

1 reference

12 December 2020

Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance

1 reference

12 December 2020

Functions and therapeutic roles of exosomes in cancer.

1 reference

12 December 2020

Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

1 reference

12 December 2020

Enhancing Chemotherapy Efficacy in Pten -Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity

1 reference

12 December 2020

Stress and the commensal microbiota: importance in parturition and infant neurodevelopment

1 reference

12 December 2020

Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice

1 reference

12 December 2020

Upregulation of GRP78 in renal cell carcinoma and its significance

1 reference

12 December 2020

Natural and induced T regulatory cells in cancer.

1 reference

12 December 2020

10.1007/S00109-016-1401-8

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1043899043

0 references

1 reference